What makes us unique？

·  Scientific and medical expertise in planning the full lifecycle of drug development based on different drug types. On-going projects span IND, Phase I-IV clinical trials and NDA.

·  Institutional collaborations have yielded familiarity with SSU process and requirements for EC meeting before CTA in key GCP offices and clinical trial procedures with various departments. 

·  Close collaboration with renowned experts in HIV and infections across China, and extensive iDMC resources.